BioNTech, the company behind one of the best COVID vaccines, has reported excellent results in curing an MS-like disease in mice. The treated animals showed no signs of the disease, and those that were already having MS symptoms got better. These results were recently published in the journal Science. You can find an excellent discussion of these results by the Harvard epidemiologist Eric Feigl-Ding here.
This MS vaccine uses the same MRNA approach as the two most effective COVID vaccines. BioNTech plans to use a similar technique to produce personalized cancer vaccines.
A new age in medicine may be dawning.
“Forschungszentrum der Biotech-Unternehmen BioNTech AG und Ganymed Pharmaceuticals AG” by MWKEL-RLP is licensed under CC BY-NC 2.0